Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia (SCHIZO-CV)

Université de Reims Champagne-Ardenne

Status: Unknown

Conditions: Schizophrenia

Treatments: Other: Data collection

Study type: Observational

Funder types: Other

Identifiers

NCT05174533

2021-011-SCHIZO-CV

Details and patient eligibility

About

Schizophrenia is a psychiatric disorder, affecting 600,000 patients in France. Patients with schizophrenia have life expectancy decrease from 10 to 20 years because of cardiovascular death. Cardiovascular risk factors are numerous: inadequate diet, smoking, alcohol consumption, diabetes, obesity. Primary prevention of cardiovascular risk in patients suffering from schizophrenia is difficult because of understaff in general practitioners and psychiatrists.

Full description

The aim of the study is to describe prevalence of cardiovascular disorders in patients aged 40 and more with schizophrenia.

Enrollment: 50 estimated patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• male or female
• aged of 40 and more
• with schizophrenia
• agreeing to participate in the study

Trial design

50 participants in 1 patient group

with schizophrenia

Description:

"with schizophrenia" group : patients aged 40 and more with schizophrenia

Treatment:

Other: Data collection